Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia

Biological Psychiatry

Volumn 43, Issue 1, 1998, Pages 12-19

  Yang, Chang Qing ^a   Kitamura, Noboru ^b   Nishino, Naoki ^a   Shirakawa, Osamu ^a   Nakai, Hisao ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shinko Hospital   (Japan)

Author keywords

G protein; Human brain; Immunoblotting; Limbic structure; Schizophrenia; Superior temporal cortex

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SUBUNIT;

ADULT; AGED; ALPHA CHAIN; ARTICLE; AUTOPSY; BETA CHAIN; BRAIN REGION; CHRONIC DISEASE; FEMALE; HUMAN; HUMAN TISSUE; LIMBIC CORTEX; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ASSAY; SCHIZOPHRENIA; TEMPORAL CORTEX;

EID: 0031906345     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)80250-8     Document Type: Article

References (40)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Press, Washington, DC.
2. Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry. 147:1990;1457-1462.
3. Benka ML, Lee M, Wang GR, Buckman S, Burlacu A, Cole L, et al. The thrombin receptor in human platelets is coupled to a GTP binding protein of the Gαq family. FEBS Lett. 363:1995;49-52.
4. Carlsson M, Carlsson A. Schizophrenia A subcortical neurotransmitter imbalance syndrome? Schizophr Bull. 16:1990;425-432.
5. Chua SE, McKenna. Schizophrenia - A brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psychiatry. 166:1995;563-582.
6. 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand. 86:1992;455-462.
7. Galbiati F, Guzzi F, Magee A, Milligan G, Parenti M. Chemical inhibition of myristoylation of the G protein Gi1α by 2-hydroxymyristate does not interfere with its palmitoylation or membrane association. Biochem J. 313:1996;717-720.
8. Grassie MA, McCallum JF, Guzzi F, Magee AI, Milligan G, Parenti M. The palmitoylation status of the G-protein Go1α regulates its activity of interaction with the plasma membrane. Biochem J. 302:1994;913-920.
9. Gur RE, Mozley PD, Resnick SM, Mozley LH, Shtasel DL, Gallacher MS, Arnold SE, Karp JS, Alavi A, Reivich M, Gur RC. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Arch Gene Psychiatry. 52:1995;657-667.
10. Hashimoto T, Kitamura N, Kajimoto Y, Shirai Y, Shirakawa O, Mita T, et al. Differential changes in serotonin 5-HT1A and 5-HT2 receptors in patients with chronic schizophrenia. Pharmachology. 112:1993;S35-S39.
11. Kaiya H, Nishida A, Imai A, Nakashima S, Nozawa Y. Accumulation of diacylglycerol in platelet phosphoinositide turnover in schizophrenia A biological marker of good prognosis? Biol Psychiatry. 26:1989;669-676.
12. Kapur S, Remington G. Serotonin-Dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 153:1996;466-476.
13. Kerwin RW, Patel S, Meldrum B, Czudeck C, Reynold G. Asymmetrical loss of a glutamate receptor subtype in left hippocampus in postmortem schizophrenic brain. Lancet. I:1988;583-584.
14. + channel. Nature. 337:1989;555-557.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
16. Leshner AI. Molecular mechanism of cocaine addiction. New Engl J Med. 335:1996;128-129.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;153-159.
18. Lucas JJ, Hen R. New players in the 5-HT receptor field Genes and knockouts . Trends Pharmacol Sci. 16:1995;246-252.
19. Manji HK. G proteins implications for psychiatry . Am J Psychiatry. 149:1992;746-760.
20. Memo M, Kleinman JE, Hanbauer I. Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. Science. 221:1983;1304-1307.
21. Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, et al. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry. 21:1986;1407-1414.
22. Neer EJ. Heterotrimeric G proteins Organizers of transmembrane signals . Cell. 80:1995;249-257.
23. Nestler EJ, Terwilliger RZ, Walker JR, Sevarino KA, Duman RS. Chronic cocaine treatment decreases levels of the G protein subunits Giα and Goα in discrete regions of rat brain. J Neurochem. 55:1990;1079-1082.
24. 3H]cAMP binding sites and decrease in Giα and Goα immunoreactivities in left temporal cortices from patients with schizophrenia. Brain Res. 615:1993;41-49.
25. o) in the basal ganglia of control and schizophrenic brain. J Neural Transm (GenSect). 79:1990;227-234.
26. Okada F, Crow TJ, Roberts GW. G protein (Gi, Go) in the medial temporal lobe in schizophrenia Preliminary report of a neurochemical correlate of structural change . J Neural Transm (GenSect). 84:1991;147-153.
27. Okada F, Tokumitsu Y, Takahashi N, Crow TJ, Roberts GW. Reduced concentrations of the α subunit of GTP-binding protein Go in schizophrenic brain. J Neural Transm (GenSect). 95:1994;95-104.
28. O'Leary DS, Andreasen NC, Hurtig RR, Kesler ML, Rogers M, Arndt S, et al. Auditory attentional deficits in patients with schizophrenia. Arch Gen Psychiatry. 53:1996;633-641.
29. Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley GJ. Increased dopamine-receptor sensitivity in schizophrenia. Lancet. 2:1978;223-226.
30. Petty RG, Barta PE, Pearlson GD, McGilchrist IK, Lewis RW, Tien AY, et al. Reversal of asymmetry of the planum temporale in schizophrenia. Am J Psychiatry. 152:1995;715-721.
31. Pickel VM, Joh TH, Reis DJ. Regional and ultrastructural localization of tyrosine hydroxylase by immunocytochemistry in dopaminergic neurons of the mesolimbic and nigroneostriatal systems. Adv Biochem Psychopharmacol. 16:1977;321-329.
32. Pin JP, Duvoisin R. The metabotropic glutamate receptors Structure and functions . Neuropharmacology. 34:1995;1-26.
33. 31P-NMR spectra of cats receiving lithium chloride systemically. Biol Psychiatry. 21:1986;694-698.
34. Reynolds GP. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature. 305:1983;527-529.
35. Seeman P, Niznik HB. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J. 4:1989;2737-2744.
36. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia A quantitative magnetic resonance imaging study . New Engl J Med. 327:1992;604-612.
37. Smrcka AV, Sternweis PC. Regulation of purified subtypes of phosphatidylinositol-specific phospholipase Cβ by G protein α and βγ subunits. J Biol Chem. 268:1993;9667-9674.
38. Tang WJ, Gilman AG. Adenylyl cyclases. Cell. 70:1992;869-872.
39. Taylor SJ, Chae HZ, Rhee SG, Exton JH. Activation of the β1 isozyme of phospholipase C by α subunits of the Gq class of G proteins. Nature. 350:1991;516-518.
40. Wedegaertner PB, Bourne HR. Activation and depalmitoylation of Gsα Cell. 77:1994;1063-1070.